COMMUNIQUÉS West-GlobeNewswire

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

26/08/2024 - 22:05

SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]

Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting

26/08/2024 - 22:05

Aura will Host a Virtual Ocular Oncology Investor Event Featuring Key Opinion Leaders at 8:00 am Eastern Time on September 12, 2024 BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a [...]

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

26/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]

IO Biotech Announces Participation in Upcoming Investor Conferences

26/08/2024 - 22:05

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today [...]

LifeMD to Participate in Three Investor Conferences During September

26/08/2024 - 22:05

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences [...]

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer

26/08/2024 - 22:05

SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Dhaval Patel, M.D [...]

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference

26/08/2024 - 22:05

MIAMI, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Notable Labs Announces CEO Transition

26/08/2024 - 22:05

Thomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEO Company affirms plan to initiate volasertib Phase 2 program in the coming months FOSTER CITY, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- [...]

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

26/08/2024 - 22:05

DUBLIN, Ireland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]

ClearPoint Neuro Announces Early Repayment of $10 Million Note

26/08/2024 - 22:05

SOLANA BEACH, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]

PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 22:03

MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat [...]

Third Harmonic Bio to Participate in Upcoming Investor Conferences

26/08/2024 - 22:00

SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and [...]

La Commission Européenne approuve BALVERSA®▼ (erdafitinib) chez les patients adultes atteints d’un carcinome urothélial non résécable ou métastatique

26/08/2024 - 20:57

Premier paninhibiteur de kinase des FGFR à être approuvé dans l’Espace Économique Européen, pour les adultes atteints d’un carcinome urothélial non résécable ou métastatique et pouvant présenter des altérations [...]

Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial

26/08/2024 - 20:36

Holliston, MA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company [...]

WORK Medical Technology Group LTD Announces Closing of Initial Public Offering

26/08/2024 - 19:00

Hangzhou, China, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (the "Company"), a supplier of medical devices in China, today announced the closing of the initial public offering (the [...]

AssureCare Welcomes Industry Leader Shane Powers as Vice President of Sales

26/08/2024 - 18:57

CINCINNATI, Aug. 26, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of Population Health Management solutions, is excited to announce the appointment of Shane Powers as the new Vice President of Sales. Shane [...]

Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 18:26

Media Release COPENHAGEN, Denmark; August 26, 2024 Genmab A/S (Nasdaq: GMAB ) a nnounced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano will participate in a [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2024

26/08/2024 - 18:19

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

26/08/2024 - 18:15

KUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its RM 1 [...]